Sveriges mest populära poddar
Hematologic Oncology Update
Hälsa och motionMedicin

Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review

1 tim 1 min•21 januari 2026

Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouver, Canada, discuss clinical cases and recent findings from the 2025 ASH Annual Meeting relating to the use of bispecific antibodies in the management of lymphoma.

CME information and select publications here.

Fler avsnitt av Hematologic Oncology Update

Visa alla avsnitt av Hematologic Oncology Update
Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
•25 min
CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
•24 min
Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review
•29 min
CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah
•1 tim 3 min
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
•47 min
Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review
•19 min
Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review
•24 min
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
•58 min
Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review
•17 min
Immune Thrombocytopenia — ASH 2025 Review
•1 tim 30 min

Hematologic Oncology Update med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.